FIELD: medicine, oncology. SUBSTANCE: method involves a single subcutaneous administration of exogenic DNA obtained from sturgeon fish milt. This DNA is a powder of low-polymeric preparation containing 80% native DNA sodium salt, molecular mass - 270-500 x 103 Da, at the following ratio nitrogen bases: adenine 29.0; thymine 27.0; guanine 22.0, and cytosine 20.0. Method stimulates bone marrow hemopoiesis significantly and can be used at myelodepression caused by cytostatic therapy. EFFECT: improved method of stimulation, absence of by-side effects.
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION AGENT FOR HEMOCORRECTION | 1993 |
|
RU2094438C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2471490C1 |
| METHOD OF CORRECTION OF ADVERSE EFFECTS OF CHEMISTRY-RADIATION THERAPY | 1995 |
|
RU2110995C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
| METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
| LIPOSOME PHARMACEUTICAL PREPARATION AND TREATMENT-AND-PROPHYLACTIC CREAM ON ITS BASE | 1995 |
|
RU2117474C1 |
| MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
| PREPARATION ELICITING ANTITUMOR, ANTITOXIC AND RADIOPROTECTING EFFECT | 2003 |
|
RU2234323C1 |
| AGENT AND METHOD OF ANTITUMOR ACTIVITY INCREASE AND CYTOSTATIC THERAPY BY-SIDE EFFECTS DECREASE | 1995 |
|
RU2078578C1 |
| HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
